24055495|t|Long-term oral galactose treatment prevents cognitive deficits in male Wistar rats treated intracerebroventricularly with streptozotocin.
24055495|a|Basic and clinical research has demonstrated that dementia of sporadic Alzheimer's disease (sAD) type is associated with dysfunction of the insulin-receptor (IR) system followed by decreased glucose transport via glucose transporter GLUT4 and decreased glucose metabolism in brain cells. An alternative source of energy is d-galactose (the C-4-epimer of d-glucose) which is transported into the brain by insulin-independent GLUT3 transporter where it might be metabolized to glucose via the Leloir pathway. Exclusively parenteral daily injections of galactose induce memory deterioration in rodents and are used to generate animal aging model, but the effects of oral galactose treatment on cognitive functions have never been tested. We have investigated the effects of continuous daily oral galactose (200 mg/kg/day) treatment on cognitive deficits in streptozotocin-induced (STZ-icv) rat model of sAD, tested by Morris Water Maze and Passive Avoidance test, respectively. One month of oral galactose treatment initiated immediately after the STZ-icv administration, successfully prevented development of the STZ-icv-induced cognitive deficits. Beneficial effect of oral galactose was independent of the rat age and of the galactose dose ranging from 100 to 300 mg/kg/day. Additionally, oral galactose administration led to the appearance of galactose in the blood. The increase of galactose concentration in the cerebrospinal fluid was several times lower after oral than after parenteral administration of the same galactose dose. Oral galactose exposure might have beneficial effects on learning and memory ability and could be worth investigating for improvement of cognitive deficits associated with glucose hypometabolism in AD.
24055495	15	24	galactose	ChemicalEntity	D005690
24055495	44	62	cognitive deficits	DiseaseOrPhenotypicFeature	D003072
24055495	78	82	rats	OrganismTaxon	10116
24055495	122	136	streptozotocin	ChemicalEntity	D013311
24055495	188	196	dementia	DiseaseOrPhenotypicFeature	D003704
24055495	209	228	Alzheimer's disease	DiseaseOrPhenotypicFeature	D000544
24055495	230	233	sAD	DiseaseOrPhenotypicFeature	D000544
24055495	278	294	insulin-receptor	GeneOrGeneProduct	24954
24055495	296	298	IR	GeneOrGeneProduct	24954
24055495	329	336	glucose	ChemicalEntity	D005947
24055495	351	358	glucose	ChemicalEntity	D005947
24055495	371	376	GLUT4	GeneOrGeneProduct	25139
24055495	391	398	glucose	ChemicalEntity	D005947
24055495	461	472	d-galactose	ChemicalEntity	D005690
24055495	492	501	d-glucose	ChemicalEntity	D005947
24055495	542	549	insulin	GeneOrGeneProduct	24505
24055495	562	567	GLUT3	GeneOrGeneProduct	25551
24055495	613	620	glucose	ChemicalEntity	D005947
24055495	688	697	galactose	ChemicalEntity	D005690
24055495	705	725	memory deterioration	DiseaseOrPhenotypicFeature	D008569
24055495	806	815	galactose	ChemicalEntity	D005690
24055495	931	940	galactose	ChemicalEntity	D005690
24055495	970	988	cognitive deficits	DiseaseOrPhenotypicFeature	D003072
24055495	992	1006	streptozotocin	ChemicalEntity	D013311
24055495	1016	1019	STZ	ChemicalEntity	D013311
24055495	1025	1028	rat	OrganismTaxon	10116
24055495	1038	1041	sAD	DiseaseOrPhenotypicFeature	D000544
24055495	1131	1140	galactose	ChemicalEntity	D005690
24055495	1183	1186	STZ	ChemicalEntity	D013311
24055495	1249	1252	STZ	ChemicalEntity	D013311
24055495	1265	1283	cognitive deficits	DiseaseOrPhenotypicFeature	D003072
24055495	1311	1320	galactose	ChemicalEntity	D005690
24055495	1344	1347	rat	OrganismTaxon	10116
24055495	1363	1372	galactose	ChemicalEntity	D005690
24055495	1432	1441	galactose	ChemicalEntity	D005690
24055495	1482	1491	galactose	ChemicalEntity	D005690
24055495	1522	1531	galactose	ChemicalEntity	D005690
24055495	1657	1666	galactose	ChemicalEntity	D005690
24055495	1678	1687	galactose	ChemicalEntity	D005690
24055495	1810	1828	cognitive deficits	DiseaseOrPhenotypicFeature	D003072
24055495	1845	1867	glucose hypometabolism	DiseaseOrPhenotypicFeature	D018149
24055495	1871	1873	AD	DiseaseOrPhenotypicFeature	D000544
24055495	Negative_Correlation	24954	D005947	No
24055495	Association	D003704	24954	No
24055495	Association	D000544	24954	No
24055495	Negative_Correlation	D000544	D005947	No
24055495	Positive_Correlation	D013311	D000544	No
24055495	Positive_Correlation	D013311	D003072	No
24055495	Negative_Correlation	D013311	D005690	Novel
24055495	Association	D005947	D003704	No
24055495	Association	25139	D005947	No
24055495	Association	D005690	D018149	Novel
24055495	Association	D005690	D000544	Novel
24055495	Positive_Correlation	D005690	D008569	No
24055495	Association	D005690	25551	No
24055495	Negative_Correlation	D005690	D003072	Novel